- Approval Id
- d889a9ba7818df8f
- Drug Name
- RESINSODIO POWDER 4.95 G/5 G
- Product Name
- RESINSODIO POWDER 4.95 G/5 G
- Approval Number
- SIN09521P
- Approval Date
- 1997-11-06
- Registrant
- ZYFAS MEDICAL CO
- Licence Holder
- ZYFAS MEDICAL CO
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- POWDER, FOR SUSPENSION
- Dosage
- <p><strong>Dosage and Administration</strong><br>
Administer sodium polystyrene sulfonate at least 3 hours before or 3 hours after other oral medications. Patients with gastroparesis may require a 6 hour separation.</p>
<p><strong>POSOLOGY</strong><br>
Oral administration. The average daily adult dose of the resin is 15g to 60g (approximately 3 level teaspoons one to four times daily) as a suspension in water or syrup. A suggested dose for children is up to 1g per Kg body-weight by mouth in divided doses, reduced to 500 mg per Kg. Suspension of this drug should be freshly prepared and not stored beyond 24 hours. When oral administration is difficult, Resinsodio may be administered rectally as an enema at a dose of 30-50 g in 100 ml of an aqueous vehicle (such as sorbitol solution) every 6 hours in adults, and at a dose similar to those suggested by mouth in children and neonates. The enema should be retained as long as possible (6–9 hours) and followed by a cleansing enema.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>INDICATIONS</strong><br>
Treatment of hyperkalaemia.</p>
- Contraindications
- <p><strong>CONTRAINDICATIONS</strong><br>
Resinsodio is contraindicated in patients with hypokalaemia, in patients with obstructive bowel disease, or those patients who are hypersensitive to it.</p>
- Atc Code
- V03AE01
- Atc Item Name
- polystyrene sulfonate
- Pharma Manufacturer Name
- ZYFAS MEDICAL CO
